STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME)

An extension of the STROBE statement

Valentina Gallo, Matthias Egger, Valerie McCormack, Peter B. Farmer, John P A Ioannidis, Micheline Kirsch-Volders, Giuseppe Matullo, David H. Phillips, B. Schoket, Ulf Stromberg, Roel Vermeulen, Christopher Wild, Miquel Porta, Paolo Vineis

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Advances in laboratory techniques have led to a rapidly increasing use of biomarkers in epidemiological studies. Biomarkers of internal dose, early biological change, susceptibility and clinical outcomes are used as proxies for investigating the interactions between external and/or endogenous agents and the body components or processes.The need for improved reporting of scientific research led to influential statements of recommendations such as the STrenghtening Reporting of Observational studies in Epidemiology (STROBE) statement. The STROBE initiative established in 2004 aimed to provide guidance on how to report observational research. Its guidelines provide a user-friendly checklist of 22 items to be reported in epidemiological studies, with items specific to the three main study designs: cohort studies, case-control studies and cross-sectional studies.The present STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME) initiative builds on the STROBE Statement implementing 9 existing items of STROBE and providing 17 additional items to the 22 items of STROBE checklist.The additions relate to the use of biomarkers in epidemiological studies, concerning collection, handling and storage of biological samples; laboratory methods, validity and reliability of biomarkers; specificities of study design; and ethical considerations. The STROBE-ME recommendations are intended to complement the STROBE recommendations.

Original languageEnglish
Pages (from-to)377-387
Number of pages11
JournalPreventive Medicine
Volume53
Issue number6
DOIs
Publication statusPublished - Dec 1 2011

Fingerprint

Molecular Epidemiology
Observational Studies
Epidemiology
Biomarkers
Epidemiologic Studies
Checklist
Proxy
Research
Reproducibility of Results
Case-Control Studies
Cohort Studies
Cross-Sectional Studies
Guidelines

Keywords

  • Biomarkers
  • Epidemiology
  • Molecular epidemiology
  • Reporting recommendations
  • Validation

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Epidemiology

Cite this

STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME) : An extension of the STROBE statement. / Gallo, Valentina; Egger, Matthias; McCormack, Valerie; Farmer, Peter B.; Ioannidis, John P A; Kirsch-Volders, Micheline; Matullo, Giuseppe; Phillips, David H.; Schoket, B.; Stromberg, Ulf; Vermeulen, Roel; Wild, Christopher; Porta, Miquel; Vineis, Paolo.

In: Preventive Medicine, Vol. 53, No. 6, 01.12.2011, p. 377-387.

Research output: Contribution to journalArticle

Gallo, V, Egger, M, McCormack, V, Farmer, PB, Ioannidis, JPA, Kirsch-Volders, M, Matullo, G, Phillips, DH, Schoket, B, Stromberg, U, Vermeulen, R, Wild, C, Porta, M & Vineis, P 2011, 'STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement', Preventive Medicine, vol. 53, no. 6, pp. 377-387. https://doi.org/10.1016/j.ypmed.2011.08.007
Gallo, Valentina ; Egger, Matthias ; McCormack, Valerie ; Farmer, Peter B. ; Ioannidis, John P A ; Kirsch-Volders, Micheline ; Matullo, Giuseppe ; Phillips, David H. ; Schoket, B. ; Stromberg, Ulf ; Vermeulen, Roel ; Wild, Christopher ; Porta, Miquel ; Vineis, Paolo. / STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME) : An extension of the STROBE statement. In: Preventive Medicine. 2011 ; Vol. 53, No. 6. pp. 377-387.
@article{38f308ee818c411ea1241b397cce8512,
title = "STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement",
abstract = "Advances in laboratory techniques have led to a rapidly increasing use of biomarkers in epidemiological studies. Biomarkers of internal dose, early biological change, susceptibility and clinical outcomes are used as proxies for investigating the interactions between external and/or endogenous agents and the body components or processes.The need for improved reporting of scientific research led to influential statements of recommendations such as the STrenghtening Reporting of Observational studies in Epidemiology (STROBE) statement. The STROBE initiative established in 2004 aimed to provide guidance on how to report observational research. Its guidelines provide a user-friendly checklist of 22 items to be reported in epidemiological studies, with items specific to the three main study designs: cohort studies, case-control studies and cross-sectional studies.The present STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME) initiative builds on the STROBE Statement implementing 9 existing items of STROBE and providing 17 additional items to the 22 items of STROBE checklist.The additions relate to the use of biomarkers in epidemiological studies, concerning collection, handling and storage of biological samples; laboratory methods, validity and reliability of biomarkers; specificities of study design; and ethical considerations. The STROBE-ME recommendations are intended to complement the STROBE recommendations.",
keywords = "Biomarkers, Epidemiology, Molecular epidemiology, Reporting recommendations, Validation",
author = "Valentina Gallo and Matthias Egger and Valerie McCormack and Farmer, {Peter B.} and Ioannidis, {John P A} and Micheline Kirsch-Volders and Giuseppe Matullo and Phillips, {David H.} and B. Schoket and Ulf Stromberg and Roel Vermeulen and Christopher Wild and Miquel Porta and Paolo Vineis",
year = "2011",
month = "12",
day = "1",
doi = "10.1016/j.ypmed.2011.08.007",
language = "English",
volume = "53",
pages = "377--387",
journal = "Preventive Medicine",
issn = "0091-7435",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME)

T2 - An extension of the STROBE statement

AU - Gallo, Valentina

AU - Egger, Matthias

AU - McCormack, Valerie

AU - Farmer, Peter B.

AU - Ioannidis, John P A

AU - Kirsch-Volders, Micheline

AU - Matullo, Giuseppe

AU - Phillips, David H.

AU - Schoket, B.

AU - Stromberg, Ulf

AU - Vermeulen, Roel

AU - Wild, Christopher

AU - Porta, Miquel

AU - Vineis, Paolo

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Advances in laboratory techniques have led to a rapidly increasing use of biomarkers in epidemiological studies. Biomarkers of internal dose, early biological change, susceptibility and clinical outcomes are used as proxies for investigating the interactions between external and/or endogenous agents and the body components or processes.The need for improved reporting of scientific research led to influential statements of recommendations such as the STrenghtening Reporting of Observational studies in Epidemiology (STROBE) statement. The STROBE initiative established in 2004 aimed to provide guidance on how to report observational research. Its guidelines provide a user-friendly checklist of 22 items to be reported in epidemiological studies, with items specific to the three main study designs: cohort studies, case-control studies and cross-sectional studies.The present STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME) initiative builds on the STROBE Statement implementing 9 existing items of STROBE and providing 17 additional items to the 22 items of STROBE checklist.The additions relate to the use of biomarkers in epidemiological studies, concerning collection, handling and storage of biological samples; laboratory methods, validity and reliability of biomarkers; specificities of study design; and ethical considerations. The STROBE-ME recommendations are intended to complement the STROBE recommendations.

AB - Advances in laboratory techniques have led to a rapidly increasing use of biomarkers in epidemiological studies. Biomarkers of internal dose, early biological change, susceptibility and clinical outcomes are used as proxies for investigating the interactions between external and/or endogenous agents and the body components or processes.The need for improved reporting of scientific research led to influential statements of recommendations such as the STrenghtening Reporting of Observational studies in Epidemiology (STROBE) statement. The STROBE initiative established in 2004 aimed to provide guidance on how to report observational research. Its guidelines provide a user-friendly checklist of 22 items to be reported in epidemiological studies, with items specific to the three main study designs: cohort studies, case-control studies and cross-sectional studies.The present STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME) initiative builds on the STROBE Statement implementing 9 existing items of STROBE and providing 17 additional items to the 22 items of STROBE checklist.The additions relate to the use of biomarkers in epidemiological studies, concerning collection, handling and storage of biological samples; laboratory methods, validity and reliability of biomarkers; specificities of study design; and ethical considerations. The STROBE-ME recommendations are intended to complement the STROBE recommendations.

KW - Biomarkers

KW - Epidemiology

KW - Molecular epidemiology

KW - Reporting recommendations

KW - Validation

UR - http://www.scopus.com/inward/record.url?scp=83155180331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83155180331&partnerID=8YFLogxK

U2 - 10.1016/j.ypmed.2011.08.007

DO - 10.1016/j.ypmed.2011.08.007

M3 - Article

VL - 53

SP - 377

EP - 387

JO - Preventive Medicine

JF - Preventive Medicine

SN - 0091-7435

IS - 6

ER -